UniProtKB/Swiss-Prot P10275 : Variant p.Glu682Lys 
Androgen receptor 
 
Feedback ?
 
 
Variant information 
Variant position: 
682 
The position of the amino-acid change on the UniProtKB canonical protein sequence. 
Type of variant: 
Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance  
Residue change: 
682  (E682K, p.Glu682Lys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB. 
Physico-chemical properties: 
The physico-chemical property of the reference and variant residues and the change implicated. 
BLOSUM score: 
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score:  -4 (low probability of substitution).Highest score:  11 (high probability of substitution).following page  
Variant description: 
Any additional useful information about the variant. 
Other resources: 
Links to websites of interest for the variant. 
 
 
Sequence information 
Variant position: 
682 
The position of the amino-acid change on the UniProtKB canonical protein sequence. 
Protein sequence length: 
920 
The length of the canonical sequence. 
Location on the sequence: 
 E  PGVVCAGHDNNQPDSFAALL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown. 
Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                          VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
                               VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
Rhesus macaque                 VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
Chimpanzee                     VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
Mouse                          VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
Rat                            VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
Pig                            VSHIEGYECQPIFLNVLEAIE PGVVCAGHDNNQPDSFAALL
Sequence annotation in neighborhood: 
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.  
Type Positions Description 
Chain 
1 – 920 Androgen receptor 
 
Domain 
669 – 900 NR LBD 
 
Region 
552 – 919 Interaction with LPXN 
 
Region 
592 – 919 Interaction with CCAR1 
 
Region 
625 – 919 Interaction with KAT7 
 
Alternative sequence 
645 – 920 Missing. In isoform 3. 
 
Alternative sequence 
649 – 920 Missing. In isoform 4. 
 
Mutagenesis 
702 – 702 L -> A. Alters receptor specificity, so that transcription is activated by the antiandrogen cyproterone acetate. 
 
 
 
Literature citations 
Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy. 
Hiort O.; Huang Q.; Sinnecker G.H.; Sadeghi-Nejad A.; Kruse K.; Wolfe H.J.; Yandell D.W.; 
J. Clin. Endocrinol. Metab. 77:262-266(1993) 
Cited for:  VARIANTS AIS LYS-682 AND THR-843; VARIANTS PAIS HIS-841 AND LEU-867; 
Androgen receptor gene mutations in 46,XY females with germ cell tumours. 
Chen C.P.; Chern S.R.; Wang T.Y.; Wang W.; Wang K.L.; Jeng C.J.; 
Hum. Reprod. 14:664-670(1999) 
Cited for:  VARIANT PAIS GLN-608; VARIANT AIS LYS-682; 
   
 
 
 
Disclaimer:  
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.